On May 12, 2025, President Donald Trump issued an Executive Order (EO) entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” with the goal of ensuring Americans pay no more for prescription drugs than other developed nations.
The EO directed the Secretary of Health and Human Services to communicate most-favored-nation (MFN) price targets to manufacturers
California has enacted two bills that will significantly impact private equity firms, management services organizations (MSOs), and physician practices operating in the state.
Assembly Bill 1415 (AB 1415) and Senate Bill 351 (SB 351) build on longstanding concerns about the corporate practice of medicine (CPOM) by expanding regulatory oversight of transactions and strengthening statutory prohibitions
Among the many ripples from the current government shutdown is a sudden rollback of telehealth flexibilities under Medicare that will impact both providers and beneficiaries. Greenbaum partner John Kaveney provides an overview of key issues for healthcare entities in this recently published Client Alert.
In recent weeks, vaccine policy has become a flashpoint at the state level. On September 3, 2025, the governors of Oregon, California, and Washington inaugurated a West Coast Health Alliance, a regional partnership aimed at preserving scientific integrity in vaccine policy amid growing skepticism toward federal health leadership. Through this partnership, the three states
Although much of the public commentary related to the One Big Beautiful Bill Act (OBBBA) has focused on dire predictions that millions will lose coverage, healthcare leaders – including hospital system leaders, compliance teams and finance departments – should pay close attention to the regulatory details of the bill and take proactive steps now to
An article in the August 9, 2025, issue of the New England Journal of Medicine highlights the opportunity, if not the responsibility, of the bar in the private law sector to fill the gaps in healthcare access, quality, and accountability resulting from the Trump administration’s deregulation efforts regarding federal administrative agencies and legislation. Moreover, the
An article published in the August 2025 issue of New Jersey Lawyer, a New Jersey State Bar Association publication, notes:
“The concept of artificial intelligence has permeated almost all aspects of society. AI is being implemented more and more each day by major technology companies to try to improve daily living and optimize the
The U.S. Court of Appeals for the First Circuit, in United States v. Regeneron, has joined the Sixth and Eighth Circuits in adopting the “but-for” standard to find that a violation of the Anti-Kickback Statute (AKS) triggers the False Claim Act (FCA). The First, Sixth, and Eighth Circuits have adopted the burdensome “but-for” causation standard
The medical spa industry is thriving, but with growth comes complexity, particularly in New Jersey where healthcare and professional licensing rules intersect with business and real-estate regulations. For physicians, nurses, or allied health professionals exploring a new medical spa venture, expanding an existing practice, or preparing for a sale, understanding the state’s unique requirements is